Mebias Discovery
Philadelphia, US · Founded 2015 · Delaware corporation · 1 known investors
Founders & leadership
SS
Shariff S. BayoumyNamed on SEC filing
BA
Brett A. ToungeNamed on SEC filing
LC
Lawrence C. KuoNamed on SEC filing
MS
Michael Serrano-WuNamed on SEC filing
Board
BS
Barbara SchilbergBoard directorAdvisor & Former CEO at BioAdvance
Investors · 1
Reported raises · per SEC filings
Form D private placements$3.6M disclosed across 2 rounds · 2019–2022
▶$630.7KraisedSep 2022 · 2 investors · PharmaceuticalsRule 506(b)
▶$630.7KraisedSep 2022 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Guanghui HuDirector
- Brett A. ToungeExecutive Officer, Director
- Shariff S. BayoumyExecutive Officer
- Lawrence C. KuoExecutive Officer
- Barbara SchilbergDirector
- Offering amount
- $2M
- Amount sold
- $630.7K
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedJul 2019 · 2 investors · PharmaceuticalsRule 506(b)
▶$3MraisedJul 2019 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Shariff S. BayoumyExecutive Officer
- Brett A. ToungeExecutive Officer, Director
- Barbara SchilbergDirector
- Lawrence C. KuoExecutive Officer
- Michael Serrano-WuDirector
- Offering amount
- $5.7M
- Amount sold
- $3M
- Proceeds to insiders
- $199.4K
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Mebias Discovery's investors?
- Mebias Discovery's investors include BioAdvance.
- How much funding has Mebias Discovery raised?
- Mebias Discovery has disclosed $3.6M raised across 2 rounds.
- Where is Mebias Discovery headquartered?
- Mebias Discovery is headquartered in Philadelphia, US.